S&P 500   2,470.50 (-4.41%)
DOW   20,943.51 (-4.44%)
QQQ   182.31 (-4.25%)
AAPL   240.91 (-5.26%)
FB   159.60 (-4.32%)
MSFT   152.11 (-3.55%)
GOOGL   1,102.10 (-5.15%)
AMZN   1,907.70 (-2.16%)
CGC   13.58 (-5.83%)
NVDA   243.07 (-7.79%)
BABA   187.56 (-3.56%)
MU   39.89 (-5.16%)
GE   7.04 (-11.34%)
TSLA   481.56 (-8.10%)
AMD   43.66 (-4.00%)
T   28.05 (-3.77%)
ACB   0.81 (-11.00%)
F   4.40 (-8.90%)
NFLX   364.08 (-3.04%)
BAC   19.77 (-6.88%)
GILD   72.51 (-3.01%)
PRI   84.16 (-4.88%)
DIS   94.92 (-1.74%)
S&P 500   2,470.50 (-4.41%)
DOW   20,943.51 (-4.44%)
QQQ   182.31 (-4.25%)
AAPL   240.91 (-5.26%)
FB   159.60 (-4.32%)
MSFT   152.11 (-3.55%)
GOOGL   1,102.10 (-5.15%)
AMZN   1,907.70 (-2.16%)
CGC   13.58 (-5.83%)
NVDA   243.07 (-7.79%)
BABA   187.56 (-3.56%)
MU   39.89 (-5.16%)
GE   7.04 (-11.34%)
TSLA   481.56 (-8.10%)
AMD   43.66 (-4.00%)
T   28.05 (-3.77%)
ACB   0.81 (-11.00%)
F   4.40 (-8.90%)
NFLX   364.08 (-3.04%)
BAC   19.77 (-6.88%)
GILD   72.51 (-3.01%)
PRI   84.16 (-4.88%)
DIS   94.92 (-1.74%)
S&P 500   2,470.50 (-4.41%)
DOW   20,943.51 (-4.44%)
QQQ   182.31 (-4.25%)
AAPL   240.91 (-5.26%)
FB   159.60 (-4.32%)
MSFT   152.11 (-3.55%)
GOOGL   1,102.10 (-5.15%)
AMZN   1,907.70 (-2.16%)
CGC   13.58 (-5.83%)
NVDA   243.07 (-7.79%)
BABA   187.56 (-3.56%)
MU   39.89 (-5.16%)
GE   7.04 (-11.34%)
TSLA   481.56 (-8.10%)
AMD   43.66 (-4.00%)
T   28.05 (-3.77%)
ACB   0.81 (-11.00%)
F   4.40 (-8.90%)
NFLX   364.08 (-3.04%)
BAC   19.77 (-6.88%)
GILD   72.51 (-3.01%)
PRI   84.16 (-4.88%)
DIS   94.92 (-1.74%)
S&P 500   2,470.50 (-4.41%)
DOW   20,943.51 (-4.44%)
QQQ   182.31 (-4.25%)
AAPL   240.91 (-5.26%)
FB   159.60 (-4.32%)
MSFT   152.11 (-3.55%)
GOOGL   1,102.10 (-5.15%)
AMZN   1,907.70 (-2.16%)
CGC   13.58 (-5.83%)
NVDA   243.07 (-7.79%)
BABA   187.56 (-3.56%)
MU   39.89 (-5.16%)
GE   7.04 (-11.34%)
TSLA   481.56 (-8.10%)
AMD   43.66 (-4.00%)
T   28.05 (-3.77%)
ACB   0.81 (-11.00%)
F   4.40 (-8.90%)
NFLX   364.08 (-3.04%)
BAC   19.77 (-6.88%)
GILD   72.51 (-3.01%)
PRI   84.16 (-4.88%)
DIS   94.92 (-1.74%)
Log in

NASDAQ:SLP - Simulations Plus Stock Price, Forecast & News

$32.91
-2.01 (-5.76 %)
(As of 04/1/2020 04:00 PM ET)
Today's Range
$32.23
Now: $32.91
$34.80
50-Day Range
$26.79
MA: $33.75
$38.99
52-Week Range
$19.74
Now: $32.91
$41.95
Volume123,992 shs
Average Volume152,747 shs
Market Capitalization$580.63 million
P/E Ratio65.82
Dividend Yield0.69%
Beta-0.38
Simulations Plus, Inc. develops drug discovery and development software for mechanistic modeling and simulation, and machine-learning-based prediction of properties of molecules from their structure worldwide. The company offers GastroPlus, which simulates the absorption, pharmacokinetics (PK), pharmacodynamics, and drug-drug interactions of compounds administered to humans and animals; DDDPlus that simulates in vitro laboratory experiments that measure the rate of dissolution of the drug and additives in a dosage form; and MembranePlus, which simulates laboratory experiments. It also provides PKPlus, a standalone program that provides the functionality needed by pharmaceutical industry scientists to perform the analyses and generate the outputs needed to satisfy regulatory agency requirements for NCA and compartmental PK modelling; ADMET Predictor, a chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, a molecule drawing program or sketcher. In addition, it offers MedChem Studio, a software tool for data mining and designing new molecules; KIWI, a cloud-based Web application to organizes, processes, maintains, and communicates the volume of data and results generated by pharmacologists and scientists over the duration of a drug development program; DILIsym, a quantitative systems pharmacology software; NAFLDsym, a simulation program for analyzing nonalcoholic fatty liver disease; and RENAsym for investigating and predicting drug-induced or acute kidney injury. Further, the company provides population modeling and simulation contract research services for the pharmaceutical and biotechnology industries; and clinical-pharmacology-based consulting services in support of regulatory submissions. It sells its pharmaceutical/chemistry software to pharmaceutical, biotechnology, agrochemical, cosmetics, and food companies. The company was founded in 1996 and is headquartered in Lancaster, California.
Read More
Simulations Plus logo

Industry, Sector and Symbol

Industry Computer integrated systems design
Sub-IndustryN/A
SectorComputer and Technology
Current SymbolNASDAQ:SLP
CUSIPN/A
Phone661-723-7723

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$33.97 million
Cash Flow$0.60 per share
Book Value$2.15 per share

Profitability

Net Income$8.58 million

Miscellaneous

Employees93
Market Cap$580.63 million
Next Earnings Date4/14/2020 (Estimated)
OptionableOptionable

Receive SLP News and Ratings via Email

Sign-up to receive the latest news and ratings for SLP and its competitors with MarketBeat's FREE daily newsletter.


Simulations Plus (NASDAQ:SLP) Frequently Asked Questions

How has Simulations Plus' stock been impacted by COVID-19 (Coronavirus)?

Simulations Plus' stock was trading at $30.20 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, SLP stock has increased by 9.0% and is now trading at $32.91. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Simulations Plus?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Simulations Plus in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Simulations Plus.

When is Simulations Plus' next earnings date?

Simulations Plus is scheduled to release its next quarterly earnings announcement on Tuesday, April 14th 2020. View our earnings forecast for Simulations Plus.

How were Simulations Plus' earnings last quarter?

Simulations Plus, Inc. (NASDAQ:SLP) issued its quarterly earnings data on Thursday, January, 9th. The technology company reported $0.11 earnings per share for the quarter, beating analysts' consensus estimates of $0.10 by $0.01. The technology company had revenue of $9.40 million for the quarter, compared to analysts' expectations of $8.37 million. Simulations Plus had a return on equity of 24.84% and a net margin of 25.41%. View Simulations Plus' earnings history.

How often does Simulations Plus pay dividends? What is the dividend yield for Simulations Plus?

Simulations Plus declared a quarterly dividend on Friday, January 10th. Investors of record on Monday, January 27th will be paid a dividend of $0.06 per share on Monday, February 3rd. This represents a $0.24 dividend on an annualized basis and a dividend yield of 0.73%. The ex-dividend date is Friday, January 24th. View Simulations Plus' dividend history.

What price target have analysts set for SLP?

1 equities research analysts have issued twelve-month target prices for Simulations Plus' shares. Their forecasts range from $40.00 to $40.00. On average, they expect Simulations Plus' stock price to reach $40.00 in the next twelve months. This suggests a possible upside of 21.5% from the stock's current price. View analysts' price targets for Simulations Plus.

Has Simulations Plus been receiving favorable news coverage?

News headlines about SLP stock have trended somewhat positive this week, InfoTrie Sentiment Analysis reports. InfoTrie identifies positive and negative press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Simulations Plus earned a news sentiment score of 0.6 on InfoTrie's scale. They also gave news coverage about the technology company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View the latest news aboutSimulations Plus.

Who are some of Simulations Plus' key competitors?

What other stocks do shareholders of Simulations Plus own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Simulations Plus investors own include NVIDIA (NVDA), Verizon Communications (VZ), Advanced Micro Devices (AMD), Square (SQ), Frontier Communications (FTR), QUALCOMM (QCOM), Alibaba Group (BABA), Mastercard (MA), Paypal (PYPL) and Walt Disney (DIS).

Who are Simulations Plus' key executives?

Simulations Plus' management team includes the following people:
  • Mr. Walter S. Woltosz, Co-Founder & Chairman (Age 74)
  • Mr. Shawn M. O'Connor, Chief Exec. Officer (Age 59)
  • Mr. John R. Kneisel, Chief Financial Officer (Age 61)
  • Dr. Thaddeus Henry Grasela Jr., Pharm.D., PharmD, Ph.D., Pres Buffalo Division, Director of Simulations Plus & Director (Age 65)
  • Mr. John Anthony DiBella, Pres of the Lancaster Division (Age 39)

What is Simulations Plus' stock symbol?

Simulations Plus trades on the NASDAQ under the ticker symbol "SLP."

How do I buy shares of Simulations Plus?

Shares of SLP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Simulations Plus' stock price today?

One share of SLP stock can currently be purchased for approximately $32.91.

How big of a company is Simulations Plus?

Simulations Plus has a market capitalization of $580.63 million and generates $33.97 million in revenue each year. The technology company earns $8.58 million in net income (profit) each year or $0.48 on an earnings per share basis. Simulations Plus employs 93 workers across the globe. View additional information about Simulations Plus.

What is Simulations Plus' official website?

The official website for Simulations Plus is http://www.simulations-plus.com/.

How can I contact Simulations Plus?

Simulations Plus' mailing address is 42505 10TH STREET WEST, LANCASTER CA, 93534. The technology company can be reached via phone at 661-723-7723 or via email at [email protected]


MarketBeat Community Rating for Simulations Plus (NASDAQ SLP)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  246 (Vote Outperform)
Underperform Votes:  271 (Vote Underperform)
Total Votes:  517
MarketBeat's community ratings are surveys of what our community members think about Simulations Plus and other stocks. Vote "Outperform" if you believe SLP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SLP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 4/1/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel